Roche Holding AG (OTCMKTS:RHHBY) Short Interest Update

Roche Holding AG (OTCMKTS:RHHBY) saw a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 11,741,100 shares, an increase of 467.7% from the February 13th total of 2,068,200 shares. Currently, 0.2% of the shares of the company are sold short. Based on an average daily volume of 9,269,800 shares, the days-to-cover ratio is presently 1.3 days.

Roche Trading Up 3.7 %

Shares of RHHBY stock traded up $1.56 on Thursday, reaching $43.56. 1,301,199 shares of the stock were exchanged, compared to its average volume of 2,964,496. The business’s 50 day moving average price is $39.49 and its 200 day moving average price is $38.51. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26. Roche has a twelve month low of $29.20 and a twelve month high of $43.96.

Institutional Trading of Roche

Large investors have recently made changes to their positions in the company. Bard Financial Services Inc. boosted its holdings in Roche by 37.7% in the 4th quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock valued at $3,866,000 after purchasing an additional 30,350 shares in the last quarter. Altrius Capital Management Inc boosted its stake in shares of Roche by 0.3% in the fourth quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock valued at $6,399,000 after buying an additional 603 shares in the last quarter. Diversified Trust Co grew its holdings in Roche by 1.2% during the fourth quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after acquiring an additional 711 shares during the period. Hantz Financial Services Inc. lifted its holdings in Roche by 0.9% in the fourth quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock valued at $1,176,000 after acquiring an additional 305 shares during the period. Finally, Brooklyn Investment Group grew its stake in shares of Roche by 36.6% during the 4th quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock worth $48,000 after purchasing an additional 363 shares during the period.

Analyst Ratings Changes

RHHBY has been the subject of several research analyst reports. UBS Group upgraded Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 13th. Sanford C. Bernstein raised Roche to a “strong-buy” rating in a research report on Thursday, January 30th. Finally, Morgan Stanley started coverage on shares of Roche in a research note on Wednesday, February 12th. They set an “equal weight” rating for the company. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating, one has given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.